| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma
|
Gavrielatou, N.
|
|
|
35 |
4 |
p. 340-350
|
artikel
|
| 2 |
Centralisation of care improves overall survival for sarcoma patients
|
Napolitano, A.
|
|
|
35 |
4 |
p. 338-339
|
artikel
|
| 3 |
Current strategies of cell and gene therapy for solid tumors: results of the joint international ESMO and CTIWP-EBMT survey
|
Comoli, P.
|
|
|
35 |
4 |
p. 404-406
|
artikel
|
| 4 |
Does ‘B’ stand for ‘benefit’? Decoding the B-cell neighborhood in head and neck cancer for predicting therapeutic response to PD-1 inhibitors
|
Ma, B.B.Y.
|
|
|
35 |
4 |
p. 335-337
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
35 |
4 |
p. iii
|
artikel
|
| 6 |
Improved nationwide survival of sarcoma patients with a network of reference centers
|
Blay, J.Y.
|
|
|
35 |
4 |
p. 351-363
|
artikel
|
| 7 |
Inflammatory bowel disease and risk of malignant neoplasm in the small bowel
|
Luo, X.J.
|
|
|
35 |
4 |
p. 402-404
|
artikel
|
| 8 |
Longitudinal profiling identifies co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
|
Harvey-Jones, E.
|
|
|
35 |
4 |
p. 364-380
|
artikel
|
| 9 |
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040 ☆
|
El-Khoueiry, A.B.
|
|
|
35 |
4 |
p. 381-391
|
artikel
|
| 10 |
Table of Contents
|
|
|
|
35 |
4 |
p. i-ii
|
artikel
|
| 11 |
TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes
|
Loriot, Y.
|
|
|
35 |
4 |
p. 392-401
|
artikel
|
Tijdschrift beschrijving